0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Is preoperative imaging of sentinel lymph node in breast cancer necessary? A retrospective case control study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          The necessity of preoperative lymphoscintigraphy before intraoperative sentinel lymph node (SLN) identification is still unclear. The aim of the present study was to evaluate the impact of SLN imaging on intraoperative SLN detection in breast cancer patients.

          Methods

          Retrospective, comparative, single center study of patients with breast cancer stage pT1 and pT2 who underwent axillary staging. Group 1 included patients who underwent SLN extirpation without preoperative SLN imaging, and Group 2 included patients who underwent SLN imaging prior to surgery. Differences between groups were analyzed using T-test and chi-square test.

          Results

          926 (mean age: 61.45 years) patients received subdermal injection of radiolabeled nanocolloids between tumor and axilla. SLN was identified intraoperatively in 473 of 498 patients (94.98 %) in group 1, and in 415 of 428 patients (96.96 %) in group 2 (p = 0.129). Lymphoscintigraphy detected SLN in 407 of 428 (95.09 %) patients in group 2. Due to the additional SLN imaging in group 2, the time between radiotracer injection and start of surgery was significantly prolonged (p < 0.001). A reduction of applied activity from a median of 18 MBq in group 1 to a median of 12 MBq in group 2 had no negative effect on the SLN identification.

          Conclusion

          Subdermal injection of radiolabeled nanocolloids between tumor and axilla allowed high intraoperative detection of SLN. Preoperative SLN imaging had no significant impact on the intraoperative detection but is a time-consuming and resource-intensive procedure. Prospective studies might provide further evidence to omit preoperative SLN imaging in patients with T1-2 invasive breast cancer and clinically negative axilla.

          Highlights

          • Removal of sentinel lymph nodes is a key concept in breast cancer.

          • Preoperative scintigraphy is often performed prior to SLN extirpation.

          • The contribution of imaging to intraoperative SLN identification is unclear.

          • There was no benefit of preoperative scintigraphy for intraoperative SLN detection.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: not found
          • Article: not found

          Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

            Purpose To provide current recommendations on the use of sentinel node biopsy (SNB) for patients with early-stage breast cancer. Methods PubMed and the Cochrane Library were searched for randomized controlled trials, systematic reviews, meta-analyses, and clinical practice guidelines from 2012 through July 2016. An Update Panel reviewed the identified abstracts. Results Of the eight publications identified and reviewed, none prompted a change in the 2014 recommendations, which are reaffirmed by the updated literature review. Conclusion Women without sentinel lymph node (SLN) metastases should not receive axillary lymph node dissection (ALND). Women with one to two metastatic SLNs who are planning to undergo breast-conserving surgery with whole-breast radiotherapy should not undergo ALND (in most cases). Women with SLN metastases who will undergo mastectomy should be offered ALND. These three recommendations are based on randomized controlled trials. Women with operable breast cancer and multicentric tumors, with ductal carcinoma in situ, who will undergo mastectomy, who previously underwent breast and/or axillary surgery, or who received preoperative/neoadjuvant systemic therapy may be offered SNB. Women who have large or locally advanced invasive breast cancer (tumor size T3/T4), inflammatory breast cancer, or ductal carcinoma in situ (when breast-conserving surgery is planned) or are pregnant should not undergo SNB.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              NCCN Guidelines Insights: Breast Cancer, Version 1.2017.

              These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.
                Bookmark

                Author and article information

                Contributors
                Journal
                Breast
                Breast
                The Breast : Official Journal of the European Society of Mastology
                Elsevier
                0960-9776
                1532-3080
                11 December 2024
                February 2025
                11 December 2024
                : 79
                : 103856
                Affiliations
                [a ]Clinic for Nuclear Medicine, Pius Hospital, University Medicine Oldenburg, Carl von Ossietzky University Oldenburg, 26121, Germany
                [b ]Department of Anaesthesiology and Intensive Care Medicine, Pius Hospital, University Medicine Oldenburg, Carl von Ossietzky University Oldenburg, 26121, Germany
                [c ]University Hospital for Gynecology, Pius Hospital, University Medicine Oldenburg, Carl von Ossietzky University Oldenburg, 26121, Germany
                Author notes
                [1]

                Equal contribution.

                Article
                S0960-9776(24)00187-5 103856
                10.1016/j.breast.2024.103856
                11763842
                39787816
                26c284a5-7dd1-4593-9cac-74b3ee28763d
                © 2024 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 14 June 2024
                : 18 October 2024
                : 3 December 2024
                Categories
                Original Article

                Obstetrics & Gynecology
                sentinel lymph node,breast cancer,scintigraphy
                Obstetrics & Gynecology
                sentinel lymph node, breast cancer, scintigraphy

                Comments

                Comment on this article